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ÖZ
Amaç: Preeklampsi, maternal, fetal ve neonatal morbiditenin ve 
mortalitenin en önemli nedenlerinden birisidir. Çalışmamızda 
preeklamptik anne bebeklerinin neonatal dönem prognozlarını 
araştırmak amaçlandı.
Hastalar ve Yöntemler: Çalışmaya preeklamptik ve 
normotansif annelerden doğan 36. gestasyonel haftadan küçük 
bebekler dahil edildi. Bebeklerin demografik özellikleri, neonatal 
morbiditeleri ve mortaliteleri retrospektif olarak belirlendi.
Bulgular: Çalışmaya preeklamptik annelerden doğan 140 
bebek (çalışma grubu) ile normotansif annelerden doğan 144 
bebek (kontrol grubu) dahil edildi. Çalışma grubu ve kontrol 
grubu arasında gestasyonel hafta, doğum tartısı, 1. ve 5. dakika 
Apgar skorları ve cinsiyet açısından istatistiksel olarak anlamlı 
farklılık saptanmadı. Sezeryan doğum, düşük gestasyonel hafta 
ve nötropeni oranları çalışma grubunda istatistiksel olarak 
yüksek saptandı. Nekrotizan enterokolit ve sepsis gibi neonatal 
morbiditeler de çalışma grubunda sayıca yüksek olmasına rağmen 
istatiksel anlamlılık saptanmadı. Hastaneye yatış ve mortalite 
oranları her iki grupta benzerdi.
Sonuçlar: Çalışmamızda preeklampsi, sezeryan doğum, 
düşük gestasyonel hafta ve nötropeni ile ilişkili saptandı. Diğer 
morbiditeler ve mortalite açısından iki grup arasında anlamlı fark 
saptanmadı. Bu yüzden preeklamptik anne bebeklerinin karşılaştığı 
problemlerin çoğunun preeklampsiden ziyade prematürite ve 
bununla ilişkili komplikasyonlar sonucu olduğunu düşünmekteyiz.
Anahtar kelimeler: Preeklampsi, Prematur infant, Neonatal 
mortalite, Morbidite
Introduction
Hypertensive diseases are one of the most frequent medical 
complications in pregnancy, and the main reasons of 
maternal, fetal, and neonatal morbidity and mortality [1]. 
Preeclampsia is a systemic disease of pregnancy with 
hypertension, proteinuria, and edema, which affects the fetus 
because of utero-placental deficiency, that leads to growth 
retardation [2]. Preeclampsia is reported in approximately 
2-8% of pregnancies. The incidence may vary according to 
race, region, and country [3]. The etiology of preeclampsia 
is still uncertain. Diabetes mellitus, kidney disease, obesity, 
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nulliparity, and chronic hypertension are associated with 
increased preeclampsia risk. Birth of placenta is the major 
treatment of preeclampsia. There are different articles about 
neonatal outcomes of infants born to preeclamptic mothers 
[4]. On the other hand, controversial outcomes are available 
in the current literature.
The aim of our study was to evaluate the neonatal 
outcomes of preterm infants born to preeclamptic mothers 
admitted to our clinic.
Materials and Methods
After the local ethics committee approval, we 
retrospectively evaluated the neonatal outcomes of 140 
infants born between 24 and 36 weeks of gestational age 
from preeclamptic mothers during the period from January 
2009 to December 2013 in the neonatal intensive care unit 
(NICU). The study group was compared with 144 infants 
born to normotensive mothers of the same gestational age. 
Infants with chromosomal or major congenital anomalies 
were not included. The following variables were recorded: 
maternal age, gravidity, mode of delivery, Apgar score 
(1st and 5th minute), gestational age, birth weight, sex, 
presence of small-for-gestational-age (SGA), respiratory 
distress syndrome (RDS), intraventricular hemorrhage 
(IVH), neonatal sepsis, necrotizing enterocolitis (NEC), 
bronchopulmonary dysplasia (BPD), retinopathy of 
prematurity (ROP), as well as laboratory values (leukocyte 
count, platelet count, hemoglobin), days in the NICU, 
ventilation requirement, and mortality rate.
The criteria of preeclampsia are new-onset hypertension 
(defined as systolic blood pressure ≥140 mm Hg or 
diastolic blood pressure ≥90 mm Hg) and proteinuria (300 
mg or greater in a 24-h urine specimen) after 20 weeks of 
gestation [5]. Gestational age was interpreted with obstetric 
history and early obstetric ultrasound, and verified using 
the modified Ballard examination with newborn infants’ 
clinical examination. SGA was described as being below 
the 10% percentile of the recommended sex-specific birth 
weight for gestational age reference curves. RDS was 
described as clinical findings (tachypnea, retractions or 
nasal flaring, grunting respiration, and possible central 
cyanosis) and radiologic findings (reticular granular pattern 
or air bronchograms) [6]. IVH was identified using the 
Papile classification system [7]. For the identification of 
neonatal sepsis, we interpreted the clinical signs of systemic 
inflammation (temperature instability, apnea, respiratory 
distress, seizures, tachypnea, bradycardia, abdominal 
distension and vomiting), routine laboratory tests such as 
leukocytosis or leukopenia and C-reactive protein (CRP) 
results > 1mg/dL, and if possible we isolated the causal 
microorganisms from blood cells or cerebrospinal fluid 
culture [8]. NEC was categorized in conformity with the 
modified Bell’s criteria [9]. The criteria for diagnosis of BPD 
were oxygen dependency at 28 days of life or longer along 
with a concordant chest radiograph. Moderate to severe BPD 
in preterm neonates with less than 32 weeks of gestational 
age was described as dependence on supplemental oxygen at 
36 weeks of postconceptional age [10]. ROP was categorized 
in accordance with the International Classification of ROP 
[11]. Thrombocytopenia was described as a platelet count 
of <150 000 /mm3. Polycythemia was identified as a central 
venous hematocrit (Hct) level greater than 65%, leukopenia 
was described as a leukocyte count of <5000 /mm3, and 
leukocytosis was identified as a leucocyte count of >21 000 
/mm3 two days after the day of birth.
Data was analyzed using the Number Cruncher Statistical 
System (NCSS) 2007 (Utah, USA) statistical software. 
Descriptive statistics are given as mean ±SD, median, and 
interquartile range. The independent t-test was used in 
the comparison of variables with normal distribution, and 
the Mann-Whitney U test was used in the comparison of 
variables with non-normal distribution. For the comparison 
of qualitative data, Pearson’s Chi-square, Fisher’s exact, 
and Fisher-Freeman-Halton tests were used. A P value 
<0.05 was considered statistically significant.
Results
A total of 284 infants, 140 born to preeclamptic mothers 
(study group) and 144 born to normotensive mothers (control 
group) were included in the study. The mean gestational age 
of the study and control groups were 31.5±3.2 and 30.9±3.1 
weeks, respectively (p>0.05). The mean birth weights of 
the study and control groups were similar (1592±493 and 
1596±491 g, respectively). There were also no statistically 
significant differences between the groups with regards to 
sex, mean Apgar scores at 1 and 5 minutes, and rates of 
antenatal corticosteroid use (p>0.05). The cesarean birth 
rate in infants of the study and control groups was 98.6% 
and 73.6%, respectively, and the difference was statistically 
significant (p<0.01). The rate of SGA in infants in the study 
group was also significantly higher compared with the 
control group (p<0.01). Demographic data of the patients 
are summarized in Table I.
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Neonatal thrombocytopenia was diagnosed in 60 
(42.9%) infants in the study group and 58 (40.3%) in 
the control group; there was no significant difference 
between the groups. Neutropenia was diagnosed in 33 
(23.6%) infants of study group and 16 (11.1%) in the 
control group, the difference between the two groups was 
statistically significant (p<0.05). The mean duration of 
neutropenia was 11 days (range, 2-25 days) and 6.5 days 
(range, 1-36.5 days) in the study and the control group, 
respectively. Although the difference was not statistically 
significant, the duration of neutropenia was longer in the 
study group. Neonatal sepsis was diagnosed in 22 (15.7%) 
infants in the study group and in 16 (11.1%) in the control 
group; this difference was not significant. There were no 
significant differences in terms of neonatal polycythemia, 
RDS, ROP, IVH, NEC, duration of mechanical ventilation, 
duration of hospital stay, and BPD between the study 
and control groups. Mortality rates were also similar 
between the study and control groups (7.9% and 11..8%, 
respectively). Neonatal outcomes among the study and 
control groups are summarized in Table II. There were no 
significant differences between the two groups in terms of 
abnormal neurologic examination findings and incidence 
of periventricular leucomalacia at discharge.
Table I. Demographic features of study and control groups
Demographic feature Study group (n=140) Control group (n=144) P value
Sex (male/female) 73/67 75/69 > 0.05
Gestational age (week) 31.5±3.2 30.9±3.1 > 0.05
Cesarean delivery, n (%) 138 (98.6) 106 (73.6) < 0.01
Small for gestational age (SGA), n (%) 17 (12.1) 3 (2.1) < 0.01
Birth Weight (g) 1592±492 1596±491 > 0.05
Apgar score at 1st minute 6.26±2.10 6.21±1.85 >0.05
Apgar score at 5th minute
Antenatal corticosteroid, n (%)
8.67±1.08
37(63.8)
8.63±1.10
45(6.2)
> 0.05
> 0.05
Table II. Perinatal outcomes and laboratory findings of the study and control groups
Perinatal Outcomes Study group (n=140) Control group (n=144) P value
Duration of mechanical ventilation (days) 8.9±30.3 7.4±14.0 > 0.05
Primary hospital stay (days) 30.7±34.5 32.5±28.7 > 0.05
Thrombocytopenia, n (%) 60 (42.9) 58 (40.3) > 0.05
Neutropenia, n (%) 33 (23.6) 16 (11.1) < 0.05
Polycythemia, n (%) 4 (2.9) 4 (2.8) > 0.05
RDS, n (%) 69 (49.3) 81 (56.3) > 0.05
IVH, n (%) 27 (19.3) 24 (16.7) > 0.05
NEC, n (%) 22 (15.7) 16 (11.1) > 0.05
Sepsis, n (%) 22 (15.7) 16 (11.1) > 0.05
BPD, n (%) 13 (9.3) 16 (11.1) >0.05
ROP, n (%) 8 (5.7) 8 (5.5) > 0.05
Neonatal mortality, n (%) 11 (7.9) 17 (11.8) > 0.05
RDS: respiratory distress syndrome, IVH: intraventricular hemorrhage, NEC: necrotizing enterocolitis, BDP: bronchopulmonary dysplasia, ROP: retino-
pathy of prematurity 
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We further classified groups into two subgroups 
according to the gestational weeks, group 1: 24-32 weeks, 
and group 2: 32-36 weeks. Group 1 consisted of 126 infants 
(58 from the study group, 68 from the control group), and 
group 2 comprised 158 infants (82 from the study group, 
76 from the control group). Among patients in group 1, the 
duration of mechanical ventilation was significantly longer 
in infants from the study group when compared with the 
control group (15.1±21.9 vs 11.9±18 days) (p<0.01). No 
significant difference was determined between the study and 
control groups in terms of neonatal morbidity, mortality, and 
laboratory findings when compared separately regarding the 
gestational ages in groups 1 and 2 (p>0.05).
Discussion
Preeclampsia was related to maternal and perinatal 
incidence of mortality, morbidity, and prematurity [12]. The 
time of initiation of preeclampsia in pregnancy and severity 
of the disease, performed obstetric care approaches, and 
level of nursing in NICUs affect the results in infants. In the 
present study, we aimed to investigate neonatal outcomes of 
infants born to preeclamptic mothers. In our study, neonatal 
outcomes of infants of preeclamptic mothers were generally 
similar to the outcomes of infants of normotensive mothers. 
However, cesarean delivery rates and SGA birth rates were 
significantly higher in the study group than in the control 
group.
Different results have been reported linked to the results 
of infants born to preeclamptic mothers in the literature. 
Saadat et al. [13] showed that cesarean delivery was more 
frequent in preeclamptic mothers (30%) as compared with 
normotensive mothers (13%). Çetinkaya et al. also found 
that the rate of cesarean delivery was higher in preeclamptic 
mothers than in normotensive mothers (78% vs. 60%) but 
the difference was not statistically significant (p>0.05) [14]. 
Similarly, the frequency of cesarean delivery was higher 
in our study group, but the difference was statistically 
significant (p<0.01).
Bülbül et al. found that the rate of SGA infants in their 
preeclampsia group was higher but the difference was not 
statistically significant (14-17%, p>0.05) [3]. Similarly, 
Anand et al. showed that the incidence of SGA infants was 
four times more common in the hypertensive group (44.5% 
vs. 11%) [15]. We also showed that the rate of SGA infants 
was statistically significantly higher in the study group 
compared with the control group (p<0.01).
There were different results linked to RDS when infants 
born to preeclamptic mothers and normotensive mothers 
were checked. Interestingly, Langenveld et al. showed that 
the risk of RDS was reduced in infants of preeclamptic 
mothers who were delivered between 34 and 37 weeks of 
gestation compared with controls born to normotensive 
mothers [16]. In contrast, Chang et al. showed an increased 
risk of RDS in early preeclamptic premature infants with 
<32 weeks of gestational age [17]. Cheng et al. reported 
no differences between preeclamptic and control infants 
in terms of respiratory outcomes [4]. In the current study, 
we found no differences between preeclamptic and control 
infants in terms of RDS. Differences in RDS description 
and the retrospective analysis of RDS may explain for these 
variations. We also stated that time of mechanical ventilation 
and BPD showed no variation between the two groups. 
However, when we encountered the gestational week 
subgroups (group 1: 24-32 weeks, group 2: 32-36 weeks), 
the duration of mechanical ventilation was significantly 
longer in the study group compared with the control group 
among infants with 24-32 weeks of gestational age. Based 
on these results, we can argue that preeclampsia widens 
the duration of mechanical ventilation in infants with 
gestational age of less than 32 weeks. We could not find 
any similar studies in the literature; therefore, we believe 
that larger studies are warranted to investigate respiratory 
outcomes of infants born to preeclamptic mothers.
Intraventricular hemorrhage is a critical complication 
seen in premature infants. IVH is one of the major significant 
reason of neonatal morbidity that may cause brain damage 
resulting in cognitive and motor disabilities, cerebral palsy, 
and mental retardation [18]. Cheng et al. reported an IVH 
rate of 50% for infants born to preeclamptic mothers and 
26% for controls [4]. In contrast, Çetinkaya et al. determined 
that the difference in IVH incidence was not statistically 
significant when infants born to preeclamptic mothers were 
compared with controls [14]. We found similar results in our 
study. We do not know the long-term neurologic results of 
these infants because this was a retrospective study, which 
may be the topic of a new study.
Neutropenia has been showed in infants of preeclamptic 
mothers with an incidence of 50% [19]. Neutropenia may be 
related with an increased risk of nosocomial infections. Gray 
and Rodwell [20] concluded that prolonged neutropenia 
might be responsible for the increased incidence of 
nosocomial infections in infants born to preeclamptic 
mothers. Conflictingly, Paul et al. [21] showed that 
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very-low-birth-weight infants born to preeclamptic mothers 
were not at increased risk of culture-proven sepsis despite a 
reduction in an absolute number of neutrophils. In our study, 
the prevalence of neutropenia among infants of preeclamptic 
mothers was 23.6%, which was statistically significantly 
more common compared with infants of normotensive 
mothers (p<0.05). Neonatal sepsis was also found more 
common in infants born to preeclamptic mothers. This 
result shows that neutropenia can be demonstrated as a 
cause of sepsis. There are many predisposing factors for 
sepsis. The risk of sepsis in infants born to preeclamptic 
mothers is still controversial. Maternal preeclampsia was 
also described as a cause of neonatal thrombocytopenia 
[22]. Thrombocytopenia is generally identified at birth or 
within the first 2-3 days after delivery, with resolution in 10 
days in most cases [23]. Thrombocytopenia was also higher 
in the study group, but not statistically significantly (42.9% 
vs. 40.3%). Different incidences of thrombocytopenia have 
been reported, up to as much as 36% by Bhat et al. [24].
Necrotizing colitis is a serious reason of mortality and 
morbidity in preterm infants. Although the pathophysiology 
of NEC is multifactorial, prematurity, low birth weight, 
enteral feeding, and neonatal infection are obvious 
predisposing factors for the occurrence of NEC [25]. There 
are a variety of outcomes in the literature about preeclampsia 
and its relationship with NEC. Bashiri et al. reported an 
association between maternal hypertensive disorders and 
NEC in very-low-birth- weight infants [25]. In contrast, 
Hiett et al. stated that NEC was not increased in infants born 
to preeclamptic mothers [26]. In our study, in agreement 
with the latter, the incidence of NEC was higher in infants 
born to preeclamptic mothers, but the difference between 
the two groups was not statistically significant.
Preterm infants are at an elevated risk for ROP. Zayed et 
al. found no associations between gestational hypertension 
and ROP severity score [27]. Filho et al. reported that 
preeclampsia decreased the risk of retinopathy of prematurity 
occurrence in very-low-birth-weight infants [28]. Dan Yu 
et al. also showed that preeclampsia was associated with a 
significantly lowered risk of ROP [29]. On the other hand, 
Çetinkaya et al. reported that there were no significant 
differences in terms of ROP between their study and control 
groups (P>0.05) [14]. In our study, we found similar results 
regarding the incidence of ROP.
There are contraversial results about the mortality 
ratio of infants born to preeclamptic mothers. Çetinkaya 
et al. reported that there were no significant differences 
in mortality rates between infants born to preeclamptic 
mothers compared with control infants [14]. Güran et 
al. showed that mortality (18.9% vs. 26.9%, p=0.23) was 
lower in infants of preeclamptic mothers although there was 
no statistically significant difference [3]. In our study, we 
found that the mortality rate was lower in the preeclamptic 
group compared with controls, but the difference was not 
statistically significant (7.8% vs. 11.8%).
There are limitations to our study. First, our study was 
retrospective and based on the results of a single center 
and included a small number of patients. There is a need 
for further prospective studies on this issue with a greater 
number of patients. Secondly, the severity of preeclampsia 
was not considered as a variable in our study. Finally, we 
were unable to follow long term results of the patients so 
after discharge status of patients are unknown. Therefore, 
we could not determine the long-term neurocognitive and 
respiratory outcomes of our patients.
Conclusion
In the present study, preeclampsia was associated with 
increased rates of SGA, cesarean births, neutropenia, and 
extended duration of mechanical ventilation among infants 
born below 32 weeks of gestational age. Neonatal morbidity 
and mortality rates were similar between infants born to 
preeclamptic or normotensive mothers. These findings 
indicate that neonatal outcomes of preeclampsia were 
dependent on prematurity and were related to premature 
deliveries of preeclamptic women, not only preeclampsia 
itself.
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